Chemotherapy-free, triple combination of obinutuzumab, venetoclax and idasanutlin: antitumor activity in xenograft models of non-Hodgkin lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 15 September 2017 |
| Author/s |
author: Christian Klein |
| Publication date | September 15, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |